BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19852819)

  • 1. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4.
    Sarkar S; Cooney LA; White P; Dunlop DB; Endres J; Jorns JM; Wasco MJ; Fox DA
    Arthritis Res Ther; 2009; 11(5):R158. PubMed ID: 19852819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice.
    Zhou X; Hua X; Ding X; Bian Y; Wang X
    J Clin Immunol; 2011 Jun; 31(3):395-405. PubMed ID: 21305388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses.
    Justa S; Zhou X; Sarkar S
    PLoS One; 2014; 9(3):e93279. PubMed ID: 24676270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma.
    Kelchtermans H; Schurgers E; Geboes L; Mitera T; Van Damme J; Van Snick J; Uyttenhove C; Matthys P
    Arthritis Res Ther; 2009; 11(4):R122. PubMed ID: 19686583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Th1 and Th17 Responses and Induction of Treg Responses by IL-18-Expressing Plasmid Gene Combined with IL-4 on Collagen-Induced Arthritis.
    Dai Q; Li Y; Yu H; Wang X
    Biomed Res Int; 2018; 2018():5164715. PubMed ID: 29854762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis.
    Mauri C; Williams RO; Walmsley M; Feldmann M
    Eur J Immunol; 1996 Jul; 26(7):1511-8. PubMed ID: 8766554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
    Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
    Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Schistosoma japonicum infection on collagen-induced arthritis in DBA/1 mice: a murine model of human rheumatoid arthritis.
    Song X; Shen J; Wen H; Zhong Z; Luo Q; Chu D; Qi Y; Xu Y; Wei W
    PLoS One; 2011; 6(8):e23453. PubMed ID: 21858123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary inflammation in mice with collagen-induced arthritis is conditioned by complete Freund's adjuvant and regulated by endogenous IFN-γ.
    Schurgers E; Mertens F; Vanoirbeek JA; Put S; Mitera T; De Langhe E; Billiau A; Hoet PH; Nemery B; Verbeken E; Matthys P
    Eur J Immunol; 2012 Dec; 42(12):3223-34. PubMed ID: 22930199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions.
    Yokoyama Y; Iwasaki T; Kitano S; Satake A; Nomura S; Furukawa T; Matsui K; Sano H
    J Immunol; 2018 Oct; 201(7):1899-1906. PubMed ID: 30143591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis.
    Olalekan SA; Cao Y; Finnegan A
    Arthritis Res Ther; 2014 Sep; 16(5):440. PubMed ID: 25253467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis.
    Marchesan JT; Gerow EA; Schaff R; Taut AD; Shin SY; Sugai J; Brand D; Burberry A; Jorns J; Lundy SK; Nuñez G; Fox DA; Giannobile WV
    Arthritis Res Ther; 2013 Nov; 15(6):R186. PubMed ID: 24456966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local delivery of T-bet shRNA reduces inflammation in collagen II-induced arthritis via downregulation of IFN-γ and IL-17.
    Xue Y; Yang Y; Su Z; Barnie PA; Zheng D; Zhang Y; Xu Y; Wang S; Xu H
    Mol Med Rep; 2014 Mar; 9(3):899-903. PubMed ID: 24425064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
    Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
    Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis.
    Liu F; Cheng W; Pappoe F; Hu X; Wen H; Luo Q; Wang S; Deng F; Xie Y; Xu Y; Shen J
    Parasitol Res; 2016 Oct; 115(10):3795-806. PubMed ID: 27393379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.